Role of phosphatidylinositol 3-kinase pathway (PI3K/Akt) in humans

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Revista Ciencias de la Salud

• Publication date

  2009-08-01

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Key role of the p110delta isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110delta function in B cells.

  2006cited by this paper
• Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell lines

  2005cited by this paper
• Loss of heterozygosity on 10q23.3 and mutation of tumor suppressor gene PTEN in gastric cancer and precancerous lesions.

  2005cited by this paper
• The Akt-mTOR tango and its relevance to cancer.

  2005cited by this paper
• Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition.

  2005cited by this paper
• Colorectal cancer: Mutations in a signalling pathway

  2005cited by this paper
• Upregulated function of phosphatidylinositol‐3‐kinase in genetically hypertensive rats: a moderator of arterial hypercontractility

  2005cited by this paper
• A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer

  2005cited by this paper
• Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic.

  2005cited by this paper
• Phosphoinositide 3-Kinase Catalytic Subunit Deletion and Regulatory Subunit Deletion Have Opposite Effects on Insulin Sensitivity in Mice

  2005cited by this paper
• Somatic mutations of the protein kinase gene family in human lung cancer.

  2005cited by this paper
• Targeted inhibition of beta-adrenergic receptor kinase-1-associated phosphoinositide-3 kinase activity preserves beta-adrenergic receptor signaling and prolongs survival in heart failure induced by calsequestrin overexpression.

  2005cited by this paper
• AKT/PKB signaling mechanisms in cancer and chemoresistance.

  2005cited by this paper
• Essential role for the p110δ isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia

  2005cited by this paper
• Targeting Mammalian Target of Rapamycin Synergistically Enhances Chemotherapy-Induced Cytotoxicity in Breast Cancer Cells

  2004cited by this paper
• Mutations of PIK3CA in Anaplastic Oligodendrogliomas, High-Grade Astrocytomas, and Medulloblastomas

  2004cited by this paper
• Phosphatidylinositide 3-kinase gamma regulates key pathologic responses to cholecystokinin in pancreatic acinar cells.

  2004cited by this paper
• Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways

  2004cited by this paper
• Somatic mutations of EGFR in colorectal cancers and glioblastomas.

  2004cited by this paper
• A Specific Antagonist of the p110δ Catalytic Component of Phosphatidylinositol 3′-Kinase, IC486068, Enhances Radiation-Induced Tumor Vascular Destruction

  2004cited by this paper
• Erratum: A specific antagonist of the p110δ catalytic component of phosphatidylinositol 3′-kinase, IC486068, enhances radiation-induced tumor vascular destruction (Cancer Research (July 2004) 64 (4893-4899)

  2004cited by this paper
• Glucose-Potentiated Chemotaxis in Human Vascular Smooth Muscle Is Dependent on Cross-Talk Between the PI3K and MAPK Signaling Pathways

  2004cited by this paper
• Inaugural Article: The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress

  2004cited by this paper
• High Frequency of Mutations of the PIK3CA Gene in Human Cancers

  2004cited by this paper
• Role of VHL gene mutation in human cancer.

  2004cited by this paper
• Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer.

  2004cited by this paper
• The LKB1 tumor suppressor negatively regulates mTOR signaling.

  2004cited by this paper
• The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins

  2004cited by this paper
• Vascular Endothelial Growth Factor Transcriptional Activation Is Mediated by Hypoxia-inducible Factor 1α, HDM2, and p70S6K1 in Response to Phosphatidylinositol 3-Kinase/AKT Signaling*

  2004cited by this paper
• Protein Kinase C βII Regulates Akt Phosphorylation on Ser-473 in a Cell Type- and Stimulus-specific Fashion*♦

  2004cited by this paper
• PKB/Akt modulates TGF-β signalling through a direct interaction with Smad3

  2004cited by this paper
• Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers.

  2004cited by this paper
• Mechanisms of tamoxifen resistance

  2004cited by this paper
• Over-expression of the p110β but not p110α isoform of PI 3-kinase inhibits motility in breast cancer cells

  2004cited by this paper
• Mutational Analysis of the Tyrosine Phosphatome in Colorectal Cancers

  2004cited by this paper
• PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.

  2004cited by this paper
• Athletics: Momentous sprint at the 2156 Olympics?

  2004cited by this paper
• Genetic Alterations of Phosphoinositide 3‐kinase Subunit Genes in Human Glioblastomas

  2004cited by this paper
• Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy

  2004cited by this paper
• PKB/Akt modulates TGF-beta signalling through a direct interaction with Smad3.

  2004cited by this paper
• PTEN promoter is methylated in a proportion of invasive breast cancers

  2004cited by this paper
• The PIK3CA gene is mutated with high frequency in human breast cancers

  2004cited by this paper
• PTEN: One Gene, Many Syndromes

  2003cited by this paper
• Targeting the PI3K-Akt pathway in human cancer: rationale and promise.

  2003cited by this paper
• HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells

  2003cited by this paper
• Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR.

  2003cited by this paper
• Phosphorylation of p27Kip1 at Threonine 198 by p90 Ribosomal Protein S6 Kinases Promotes Its Binding to 14-3-3 and Cytoplasmic Localization*

  2003cited by this paper
• Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI 3-kinase/Akt signaling

  2003cited by this paper
• Combined trastuzumab and paclitaxel treatment better inhibits ErbB‐2‐mediated angiogenesis in breast carcinoma through a more effective inhibition of Akt than either treatment alone

  2003cited by this paper
• Tuberous sclerosis genes regulate cellular 14-3-3 protein levels.

  2003cited by this paper
• Expression of constitutively activated EGFRvlll in non‐small cell lung cancer

  2003cited by this paper
• Radiation sensitization of human cancer cells in vivo by inhibiting the activity of PI3K using LY294002.

  2003cited by this paper
• Estrogen receptor alpha forms estrogen-dependent multimolecular complexes with insulin-like growth factor receptor and phosphatidylinositol 3-kinase in the adult rat brain.

  2003cited by this paper
• PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells.

  2003cited by this paper
• Autocrine Signalling Through erbB Receptors Promotes Constitutive Activation of Protein Kinase B/Akt in Breast Cancer Cell Lines

  2003cited by this paper
• Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2.

  2003cited by this paper
• Management of cellular energy by the AMP‐activated protein kinase system

  2003cited by this paper
• Protein Kinase Bα/Akt1 Regulates Placental Development and Fetal Growth*

  2003cited by this paper
• Akt regulates growth by directly phosphorylating Tsc2

  2002cited by this paper
• Phosphatidylinositol 3-Kinase/Akt Pathway Regulates Tuberous Sclerosis Tumor Suppressor Complex by Phosphorylation of Tuberin*

  2002cited by this paper
• PKB/Akt mediates cell-cycle progression by phosphorylation of p27Kip1 at threonine 157 and modulation of its cellular localization

  2002cited by this paper
• Mutations of the BRAF gene in human cancer

  2002cited by this paper
• The phosphatidylinositol 3-Kinase–AKT pathway in human cancer

  2002cited by this paper
• Regulation of TRAIL Expression by the Phosphatidylinositol 3-Kinase/Akt/GSK-3 Pathway in Human Colon Cancer Cells*

  2002cited by this paper
• Expression of a mutated form of the p85alpha regulatory subunit of phosphatidylinositol 3-kinase in a Hodgkin's lymphoma-derived cell line (CO).

  2002cited by this paper
• Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling

  2002cited by this paper
• Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma

  2002cited by this paper
• Impaired B and T Cell Antigen Receptor Signaling in p110δ PI 3-Kinase Mutant Mice

  2002cited by this paper
• Phosphatidylinositol 3-Kinase Signaling Inhibits DAF-16 DNA Binding and Function via 14-3-3-dependent and 14-3-3-independent Pathways*

  2001cited by this paper
• Oncogenic kinase signalling

  2001cited by this paper
• Wortmannin inhibits pkb/akt phosphorylation and promotes gemcitabine antitumor activity in orthotopic human pancreatic cancer xenografts in immunodeficient mice.

  2001cited by this paper
• Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells

  2001cited by this paper
• AKT plays a central role in tumorigenesis

  2001cited by this paper
• Akt1/PKBα Is Required for Normal Growth but Dispensable for Maintenance of Glucose Homeostasis in Mice*

  2001cited by this paper
• Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation.

  2001cited by this paper
• Translational Control of the Antiapoptotic Function of Ras*

  2000cited by this paper
• TOR, a central controller of cell growth.

  2000cited by this paper
• Mapping of AKT3, encoding a member of the Akt/protein kinase B family, to human and rodent chromosomes by fluorescence in situ hybridization

  2000cited by this paper
• The ARF/p53 pathway.

  2000cited by this paper
• Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.

  2000cited by this paper
• Protein-protein interactions define specificity in signal transduction.

  2000cited by this paper
• Specificity and mechanism of action of some commonly used protein kinase inhibitors.

  2000cited by this paper
• Centrosome hyperamplification in human cancer: chromosome instability induced by p53 mutation and/or Mdm2 overexpression

  1999cited by this paper
• HER-2/neu amplification and overexpression in endometrial carcinoma.

  1999cited by this paper
• Proliferative Defect and Embryonic Lethality in Mice Homozygous for a Deletion in the p110α Subunit of Phosphoinositide 3-Kinase*

  1999cited by this paper
• Integrin-linked kinase regulates phosphorylation of serine 473 of protein kinase B by an indirect mechanism

  1999cited by this paper
• PIK3CA is implicated as an oncogene in ovarian cancer

  1999cited by this paper
• Allelic loss of the PTEN region (10q23) in breast carcinomas of poor pathophenotype

  1999cited by this paper
• Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas

  1998cited by this paper
• Identification and characterization of a new oncogene derived from the regulatory subunit of phosphoinositide 3‐kinase

  1998cited by this paper
• Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization.

  1998cited by this paper
• PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer

  1997cited by this paper
• Frequent inactivation of PTEN/MMAC1 in primary prostate cancer.

  1997cited by this paper
• Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras.

  1997cited by this paper
• Radiosensitization of human tumor cells by the phosphatidylinositol3-kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay.

  1997cited by this paper
• Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA.

  1996cited by this paper
• Detection of K-ras gene mutations in non-neoplastic lung tissue and lung cancers.

  1996cited by this paper
• Mechanism of activation of protein kinase B by insulin and IGF‐1.

  1996cited by this paper
• Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas

  1995cited by this paper
• Phosphatidylinositol 3-kinase: structure and expression of the 110 kd catalytic subunit.

  1992cited by this paper

• Marine ω-3 PUFA Supplementation Enhances FFAR4 Activation and Reduces Inflammatory Markers in PBMC of Subjects with Obesity: A Randomized Controlled Trial (EPICO)

  2025cites this paper
• Epicardial Fat: Physiological, Pathological, and Therapeutic Implications

  2016cites this paper
• Boletín del colegio Mexicano de Urología

  year unknowncites this paper